← 返回

TIL(肿瘤浸润淋巴细胞)作为过继性细胞疗法的疗效:一项整合性综述

英文原题:Efficacy of treatment with tumor-infiltrating lymphocytes as adoptive cell therapy: an integrative review.

查看英文原题

Efficacy of treatment with tumor-infiltrating lymphocytes as adoptive cell therapy: an integrative review.

PubMed 2024/12/16(内容时间) Einstein (Sao Paulo) Q3 · IF 1.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

本综述表明,使用 TIL(肿瘤浸润淋巴细胞)的过继性细胞疗法显示出疗效,尤其是在转移性黑色素瘤的治疗中,并在治疗实体瘤方面展现出相当大的前景。

研究思路结论见上方概要

本综述文章探讨了使用TIL(肿瘤浸润淋巴细胞)的过继细胞疗法的疗效,特别关注黑色素瘤和其他实体瘤的治疗。

方法学包括主题定义、全面的数据库检索以及对相关文献的批判性综述。在最初识别的1,947篇文章中,根据严格的纳入和排除标准,精心筛选出15篇。

研究结果表明,基于TIL(肿瘤浸润淋巴细胞)的疗法在治疗转移性黑色素瘤方面特别有效,其定制化方法和巨大潜力已得到证实。然而,这些发现对其他实体瘤类型的适用性仍然有限。

展开英文摘要原文

This integrative review article examines the efficacy of adoptive cell therapy using tumor-infiltrating lymphocytes, with a particular focus on the treatment of melanomas and other solid tumors.

The methodology encompasses theme definition, comprehensive database searches, and a critical review of pertinent literature. Of the 1,947 articles initially identified, 15 were meticulously selected based on stringent inclusion and exclusion criteria.

The findings suggest that tumor-infiltrating lymphocytes-based therapy is particularly effective in treating metastatic melanomas, as noted by its tailored approach and substantial potential. However, the applicability of these findings to other solid tumor types remains limited.

This review indicates that adoptive cell therapy using tumor-infiltrating lymphocytes demonstrates efficacy, especially in the treatment of metastatic melanoma, and shows considerable promise for treating solid tumors.

论文信息

作者
Silva LMSD、Gomes ESB、Vieira JH、Aguiar MP、Silva SFMD、Michelin MA
单位
Instituto de Pesquisa em Oncologia, Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brazil.Brazil
文献类型
综述
期刊
Einstein (Sao Paulo, Brazil)2024
原文标识
PubMed 39699412 · DOI 10.31744/einstein_journal/2024RW0935